<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Dexcom Inc — News on 6ix</title>
<link>https://6ix.com/company/dexcom-inc</link>
<description>Latest news and press releases for Dexcom Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 29 Apr 2026 08:31:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/dexcom-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835606778dffbe2df0edfe9.webp</url>
<title>Dexcom Inc</title>
<link>https://6ix.com/company/dexcom-inc</link>
</image>
<item>
<title>Middle East and Africa Continuous Glucose Monitoring Market Forecast and Company Analysis Report 2026-2034 Featuring Dexcom, Medtronic, Senseonics, Abbott Diabetes Care, and GlySens</title>
<link>https://6ix.com/company/dexcom-inc/news/middle-east-and-africa-continuous-glucose-monitoring-market-forecast-and-company-analysis-report-2026-2034-featuring-dexcom-medtronic-senseonics-abbott-diabetes-care-and-glysens</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/middle-east-and-africa-continuous-glucose-monitoring-market-forecast-and-company-analysis-report-2026-2034-featuring-dexcom-medtronic-senseonics-abbott-diabetes-care-and-glysens</guid>
<pubDate>Wed, 29 Apr 2026 08:31:00 GMT</pubDate>
<description>The Middle East and Africa Continuous Glucose Monitoring (CGM) market is set for growth, driven by increasing diabetes rates, technological advancements, and healthcare awareness. Projected to rise from USD 320.44 million in 2025 to USD 855.30 million by 2034 at an 11.53% CAGR, this market benefits from enhanced healthcare infrastructure and digital health integration. Key factors include the prevalence of diabetes in Saudi Arabia, South Africa, UAE, and Egypt, influencing CGM adoption. Governme</description>
</item>
<item>
<title>Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time</title>
<link>https://6ix.com/company/dexcom-inc/news/dexcom-schedules-first-quarter-2026-earnings-release-and-conference-call-for-april-30-2026-at-430-pm-eastern-time-51</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/dexcom-schedules-first-quarter-2026-earnings-release-and-conference-call-for-april-30-2026-at-430-pm-eastern-time-51</guid>
<pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2026 financial results after market close</description>
</item>
<item>
<title>Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026</title>
<link>https://6ix.com/company/dexcom-inc/news/dexcom-showcases-breakthrough-outcomes-for-people-with-type-2-diabetes-and-product-roadmap-at-attd-2026</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/dexcom-showcases-breakthrough-outcomes-for-people-with-type-2-diabetes-and-product-roadmap-at-attd-2026</guid>
<pubDate>Wed, 11 Mar 2026 04:00:00 GMT</pubDate>
<description>New registry study data shows that long-term use of Dexcom G7 supports weight management and lowers A1C for people with Type 2 diabetes who aren’t on insulin</description>
</item>
<item>
<title>Dexcom Appoints Rick Osterloh to Board of Directors</title>
<link>https://6ix.com/company/dexcom-inc/news/dexcom-appoints-rick-osterloh-to-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/dexcom-appoints-rick-osterloh-to-board-of-directors</guid>
<pubDate>Thu, 26 Feb 2026 21:15:00 GMT</pubDate>
<description>SAN DIEGO, February 26, 2026--Dexcom Appoints Rick Osterloh to Board of Directors</description>
</item>
<item>
<title>Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results</title>
<link>https://6ix.com/company/dexcom-inc/news/dexcom-reports-fourth-quarter-fiscal-210300764</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/dexcom-reports-fourth-quarter-fiscal-210300764</guid>
<pubDate>Thu, 12 Feb 2026 21:03:00 GMT</pubDate>
<description>SAN DIEGO, February 12, 2026--Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results</description>
</item>
<item>
<title>Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care</title>
<link>https://6ix.com/company/dexcom-inc/news/insulet-launches-omnipodr-5-and-omnipod-discovertm-in-the-middle-east-to-transform-diabetes-care</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/insulet-launches-omnipodr-5-and-omnipod-discovertm-in-the-middle-east-to-transform-diabetes-care</guid>
<pubDate>Thu, 05 Feb 2026 12:00:00 GMT</pubDate>
<description>ACTON, Mass., February 05, 2026--Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care</description>
</item>
<item>
<title>Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management</title>
<link>https://6ix.com/company/dexcom-inc/news/stelo-adds-enhanced-smart-meal-133000314</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/stelo-adds-enhanced-smart-meal-133000314</guid>
<pubDate>Wed, 04 Feb 2026 13:30:00 GMT</pubDate>
<description>SAN DIEGO, February 04, 2026--Dexcom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled enhancement to Stelo that will transform how users understand their glucose health and take steps in achieving their long-term health goals. The newest features will launch nationwide in the coming weeks.</description>
</item>
<item>
<title>Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.</title>
<link>https://6ix.com/company/dexcom-inc/news/dexcom-schedules-fourth-quarter-fiscal-133000856</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/dexcom-schedules-fourth-quarter-fiscal-133000856</guid>
<pubDate>Tue, 27 Jan 2026 13:30:00 GMT</pubDate>
<description>SAN DIEGO, January 27, 2026--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and fiscal year 2025 financial results after market close on Thursday, February 12, 2026. Management will hold a conference call to review the company's fourth quarter and fiscal year 2025 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations webs</description>
</item>
<item>
<title>Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook</title>
<link>https://6ix.com/company/dexcom-inc/news/dexcom-reports-preliminary-unaudited-results-123000131</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/dexcom-reports-preliminary-unaudited-results-123000131</guid>
<pubDate>Mon, 12 Jan 2026 12:30:00 GMT</pubDate>
<description>SAN DIEGO, January 12, 2026--Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook</description>
</item>
<item>
<title>Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer</title>
<link>https://6ix.com/company/dexcom-inc/news/dexcom-enters-next-era-continued-innovation-jake-leach-president-and-chief-executive</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/dexcom-enters-next-era-continued-innovation-jake-leach-president-and-chief-executive</guid>
<pubDate>Wed, 07 Jan 2026 05:00:00 GMT</pubDate>
<description>Mr. Leach begins his inaugural year as CEO with speaking engagements at CES 2026 and the 44th annual J.P. Morgan Healthcare Conference A completely</description>
</item>
<item>
<title>Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy</title>
<link>https://6ix.com/company/dexcom-inc/news/listening-healthcare-professionals-dexcom-launches-new-education-offering-dexcom</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/listening-healthcare-professionals-dexcom-launches-new-education-offering-dexcom</guid>
<pubDate>Thu, 04 Dec 2025 05:00:00 GMT</pubDate>
<description>New personalised learning platform aims to build confidence in healthcare professional (HCP) CGM knowledge, no matter their previous experience, and support</description>
</item>
<item>
<title>GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program</title>
<link>https://6ix.com/company/dexcom-inc/news/glucoguard-a-division-of-american-diversified-holdings-adhc-successfully-submits-level-2-app-integration-through-dexcoms-developer-partner-program-1</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/glucoguard-a-division-of-american-diversified-holdings-adhc-successfully-submits-level-2-app-integration-through-dexcoms-developer-partner-program-1</guid>
<pubDate>Tue, 25 Nov 2025 14:00:00 GMT</pubDate>
<description>Del Mar, California--(Newsfile Corp. - November 25, 2025) - American Diversified Holdings Corporation (OTCID: ADHC) announced today that GlucoGuard has completed the Level 2 App integration through DEXCOM's Developer Program. The project development is in conjunction with UC Irvine's MADO program through the California Institute for Telecommunications and Information Technology (CALIT2a).The Dexcom Developer Program is a partnership program that allows developers to access Dexcom API and...</description>
</item>
<item>
<title>Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States</title>
<link>https://6ix.com/company/dexcom-inc/news/dexcom-g7-15-day-continuous-glucose-monitoring-system-launch-dec-1-united-states-2025</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/dexcom-g7-15-day-continuous-glucose-monitoring-system-launch-dec-1-united-states-2025</guid>
<pubDate>Thu, 20 Nov 2025 05:00:00 GMT</pubDate>
<description>Designed to provide real-time glucose readings for an industry-leading 15.5 days*†, Dexcom G7 15 Day will be available in the U.S. for people over the age of</description>
</item>
<item>
<title>Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes</title>
<link>https://6ix.com/company/dexcom-inc/news/dexcom-smart-basal-receives-fda-clearance-becoming-first-and-only-cgm-integrated</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/dexcom-smart-basal-receives-fda-clearance-becoming-first-and-only-cgm-integrated</guid>
<pubDate>Wed, 19 Nov 2025 05:00:00 GMT</pubDate>
<description>Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers.*</description>
</item>
<item>
<title>Dexcom Reveals Global Diabetes Advocates: New Voices for Diabetes Awareness This World Diabetes Day</title>
<link>https://6ix.com/company/dexcom-inc/news/dexcom-reveals-global-diabetes-advocates-new-voices-diabetes-awareness-world-diabetes</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/dexcom-reveals-global-diabetes-advocates-new-voices-diabetes-awareness-world-diabetes</guid>
<pubDate>Fri, 14 Nov 2025 05:00:00 GMT</pubDate>
<description>Sourced from the diabetes community at large through an open call earlier this year, the 16 selected advocates represent strength, advocacy and pride in</description>
</item>
<item>
<title>Carrot Partners with ŌURA and Dexcom to Deliver Deeper Insights and Experiences for Members on Fertility, Family-Building, and Hormonal Health Journeys</title>
<link>https://6ix.com/company/dexcom-inc/news/carrot-partners-with-oura-and-dexcom-to-deliver-deeper-insights-and-experiences-for-members-on-fertility-family-building-and-hormonal-health-journeys</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/carrot-partners-with-oura-and-dexcom-to-deliver-deeper-insights-and-experiences-for-members-on-fertility-family-building-and-hormonal-health-journeys</guid>
<pubDate>Wed, 12 Nov 2025 14:00:00 GMT</pubDate>
<description>Carrot today announced a partnership with ŌURA, the world's leading smart ring, and Dexcom, the global leader in glucose biosensing, to empower members with actionable, personalized insights that support fertility and family-building goals through the metabolic-fertility program, Sprints. This collaboration combines Carrot's clinical expertise with advanced insights from ŌURA and Stelo by Dexcom, the first FDA-cleared glucose biosensor available without a prescription in the United States, empow</description>
</item>
<item>
<title>Québec Expands Access to Dexcom CGM under the Régie de l'assurance maladie du Québec (RAMQ)</title>
<link>https://6ix.com/company/dexcom-inc/news/quebec-expands-access-dexcom-cgm-under-regie-de-lassurance-maladie-du-quebec-ramq</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/quebec-expands-access-dexcom-cgm-under-regie-de-lassurance-maladie-du-quebec-ramq</guid>
<pubDate>Thu, 06 Nov 2025 05:00:00 GMT</pubDate>
<description>New RAMQ coverage means eligible Québec residents with type 2 diabetes on intensive insulin therapy can now access Dexcom Continuous Glucose Monitoring (CGM)</description>
</item>
<item>
<title>Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance</title>
<link>https://6ix.com/company/dexcom-inc/news/dexcom-reports-third-quarter-2025-financial-results-and-updates-full-year-2025</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/dexcom-reports-third-quarter-2025-financial-results-and-updates-full-year-2025</guid>
<pubDate>Thu, 30 Oct 2025 04:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2025. Third</description>
</item>
<item>
<title>Dexcom Appoints Euan Ashley to Board of Directors</title>
<link>https://6ix.com/company/dexcom-inc/news/dexcom-appoints-euan-ashley-board-directors-2025-10-27</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/dexcom-appoints-euan-ashley-board-directors-2025-10-27</guid>
<pubDate>Mon, 27 Oct 2025 04:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Euan Ashley to its Board</description>
</item>
<item>
<title>Dexcom Schedules Third Quarter 2025 Earnings Release and Conference Call for October 30, 2025 at 4:30 p.m. Eastern Time.</title>
<link>https://6ix.com/company/dexcom-inc/news/dexcom-schedules-third-quarter-2025-earnings-release-and-conference-call-october-30</link>
<guid isPermaLink="true">https://6ix.com/company/dexcom-inc/news/dexcom-schedules-third-quarter-2025-earnings-release-and-conference-call-october-30</guid>
<pubDate>Thu, 02 Oct 2025 04:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2025 financial results after market close</description>
</item>
</channel>
</rss>